FDA Clearance Tracker · K231758
NxTAG Respiratory Pathogen Panel v2 (NxTAG RPP v2)
Last checked: Nov 20, 2026Latest source record: Mar 11, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Mar 11, 2024
Substantially Equivalent
Time to decision
269 days
Received Jun 16, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K231758
- Device name
- NxTAG Respiratory Pathogen Panel v2 (NxTAG RPP v2)
- Applicant
- Luminex Molecular Diagnostics, Inc.
- Applicant location
- Toronto, CA
- Received
- Jun 16, 2023
- Decided
- Mar 11, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.3981
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QOF. The earliest in FDA's data is DEN200031, decided Mar 17, 2021.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K231758
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Luminex Molecular Diagnostics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K242613 · Decided Oct 2, 2024 · 29 days after receipt
Device type: Respiratory Virus Panel Nucleic Acid Assay System (OCC) · Laboratory Medicine & Pathology
K193167 · Decided Dec 11, 2019 · 26 days after receipt
Device type: Respiratory Virus Panel Nucleic Acid Assay System (OCC) · Laboratory Medicine & Pathology
K191161 · Decided Nov 12, 2019 · 195 days after receipt
Device type: Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System (PCH) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.